Log in

OTCMKTS:NVZMY - NOVOZYMES A/S/S Stock Price, Forecast & News

$45.58
+1.97 (+4.52 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
$44.40
Now: $45.58
$46.07
50-Day Range
$39.89
MA: $49.59
$55.28
52-Week Range
$37.99
Now: $45.58
$55.51
Volume344,607 shs
Average Volume116,815 shs
Market Capitalization$13.54 billion
P/E Ratio28.31
Dividend Yield1.19%
Beta0.72
Novozymes A/S produces and sells industrial enzymes and microorganisms worldwide. The company offers agriculture solutions, including crop protection, and animal health and nutrition solutions; fermentation, lignecellulosic hydrolysis, liquefaction, process enhancement, and saccharifaction solutions for bioenergy; baking, beverages, dairy, and protein ingredients for the food and beverage industry; and laundry, dishwashing, hand washing, and cleaning solutions for the household care industry. It also provides wastewater solutions, such as additives, biogas production, industrial bio cleaning, compound removal, odor control, and system start-up solutions; and textile solutions comprising bioscouring, bleach clean-up, desizing, denim finishing and abrasion, and biopolishing solutions. In addition, the company offers forest products that include bleach boosting, deinking, fiber modification, effluent control, pitch and stickies control, and starch modification products; and leather solutions, which comprise biopreparation, degreasing, and re-bating. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis; and rtrypsin for cell culture. Novozymes A/S has a strategic collaboration with Boehringer Ingelheim Animal Health for the research and development, production, marketing, and sale of a portfolio of probiotic products. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
Read More
NOVOZYMES A/S/S logo

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorBasic Materials
Current SymbolOTCMKTS:NVZMY
CUSIPN/A
CIKN/A
Phone45-4446-0000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.28 billion
Cash Flow$1.80 per share
Book Value$6.10 per share

Profitability

Net Income$511 million

Miscellaneous

Employees6,427
Market Cap$13.54 billion
Next Earnings Date4/2/2020 (Estimated)
OptionableNot Optionable

Receive NVZMY News and Ratings via Email

Sign-up to receive the latest news and ratings for NVZMY and its competitors with MarketBeat's FREE daily newsletter.


NOVOZYMES A/S/S (OTCMKTS:NVZMY) Frequently Asked Questions

How has NOVOZYMES A/S/S's stock been impacted by COVID-19 (Coronavirus)?

NOVOZYMES A/S/S's stock was trading at $45.0314 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, NVZMY stock has increased by 1.2% and is now trading at $45.58. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of NOVOZYMES A/S/S?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NOVOZYMES A/S/S in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for NOVOZYMES A/S/S.

When is NOVOZYMES A/S/S's next earnings date?

NOVOZYMES A/S/S is scheduled to release its next quarterly earnings announcement on Thursday, April 2nd 2020. View our earnings forecast for NOVOZYMES A/S/S.

How often does NOVOZYMES A/S/S pay dividends? What is the dividend yield for NOVOZYMES A/S/S?

NOVOZYMES A/S/S declared an annual dividend on Friday, January 24th. Shareholders of record on Friday, February 28th will be given a dividend of $0.517 per share on Tuesday, March 17th. This represents a yield of 1.01%. The ex-dividend date of this dividend is Thursday, February 27th. This is an increase from NOVOZYMES A/S/S's previous annual dividend of $0.50. View NOVOZYMES A/S/S's dividend history.

Has NOVOZYMES A/S/S been receiving favorable news coverage?

News headlines about NVZMY stock have trended somewhat positive this week, according to InfoTrie. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. NOVOZYMES A/S/S earned a news impact score of 0.8 on InfoTrie's scale. They also gave media headlines about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near term. View the latest news aboutNOVOZYMES A/S/S.

Who are some of NOVOZYMES A/S/S's key competitors?

What other stocks do shareholders of NOVOZYMES A/S/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NOVOZYMES A/S/S investors own include ManpowerGroup (MAN), TeamHealth (TMH), Novo Nordisk A/S (NVO), FOX (FOXA), Level One Bancorp (LEVL), Duke Energy (DUK), Emerson Electric (EMR), AT&T (T), Zayo Group (ZAYO) and DANSKE BK A/S/S (DNKEY).

Who are NOVOZYMES A/S/S's key executives?

NOVOZYMES A/S/S's management team includes the following people:
  • Mr. Peder Holk Nielsen, Pres & CEO (Age 63)
  • Dr. Prisca Havranek-Kosicek, CFO & Exec. VP of Corp. Functions (Age 44)
  • Mr. Thomas Videbaek, Exectuive VP & COO of Research, Innovation & Supply (Age 59)
  • Mr. Andrew Fordyce, Exec. VP of Food & Beverages (Age 56)
  • Mr. Anders Lund, Exec. VP of Household Care & Technical Industries (Age 46)

What is NOVOZYMES A/S/S's stock symbol?

NOVOZYMES A/S/S trades on the OTCMKTS under the ticker symbol "NVZMY."

How do I buy shares of NOVOZYMES A/S/S?

Shares of NVZMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is NOVOZYMES A/S/S's stock price today?

One share of NVZMY stock can currently be purchased for approximately $45.58.

How big of a company is NOVOZYMES A/S/S?

NOVOZYMES A/S/S has a market capitalization of $13.54 billion and generates $2.28 billion in revenue each year. The biotechnology company earns $511 million in net income (profit) each year or $1.75 on an earnings per share basis. NOVOZYMES A/S/S employs 6,427 workers across the globe. View additional information about NOVOZYMES A/S/S.

What is NOVOZYMES A/S/S's official website?

The official website for NOVOZYMES A/S/S is http://www.novozymes.com/.

How can I contact NOVOZYMES A/S/S?

NOVOZYMES A/S/S's mailing address is Krogshoejvej 36, Bagsvaerd G7, 2880. The biotechnology company can be reached via phone at 45-4446-0000 or via email at [email protected]


MarketBeat Community Rating for NOVOZYMES A/S/S (OTCMKTS NVZMY)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  129 (Vote Outperform)
Underperform Votes:  231 (Vote Underperform)
Total Votes:  360
MarketBeat's community ratings are surveys of what our community members think about NOVOZYMES A/S/S and other stocks. Vote "Outperform" if you believe NVZMY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVZMY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Featured Article: Current Ratio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel